Inventor · Annœullin, FR

Patricia Melnyk

10Patents
1h-index
16Co-inventors
47Inventor score

Filing activity: Nov 8, 2005 → Aug 27, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9562018B2 Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same Chemistry; Metallurgy 2 Active
US10844008B2 Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases Chemistry; Metallurgy 0 Active
US10017476B2 1,4-bis(3-aminopropyl)piperazine derivative and its use Human Necessities 0 Active
US10772884B2 Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same Chemistry; Metallurgy 0 Active
US10807958B2 1,4-bis(3-aminopropyl)piperazine derivative and its use Human Necessities 0 Active
US10179761B2 Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases Chemistry; Metallurgy 0 Active
US8680095B2 Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs Chemistry; Metallurgy 0 Active
US9714245B2 Carboline compounds usable in the treatment of neurodegenerative diseases Human Necessities 0 Active
US10537569B2 Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same Chemistry; Metallurgy 0 Active
US9044478B2 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.